Table 1 Relationship of clinical parameters with cytoplasmic and nuclear CD133 in hepatocellular carcinoma patients
CD133 (Cytoplasm) | CD133 (Nucleus) | ||||||
|---|---|---|---|---|---|---|---|
Variables | No. | Low | High | p | Low | High | p |
Age (y/o) | |||||||
<65 | 64 | 44 (69) | 20 (31) | 0.485 | 36 (56) | 28 (44) | 0.413 |
≧65 | 55 | 41 (75) | 14 (25) | 35 (64) | 20 (36) | ||
Gender | |||||||
Female | 40 | 33 (83) | 7 (17) | 0.057 | 22 (55) | 18 (45) | 0.461 |
Male | 79 | 52 (66). | 27 (34) | 49 (62) | 30 (38) | ||
Differentiation | |||||||
Undifferentiation | 4 | 3 (75) | 1 (25) | 0.551 | 2 (50) | 2 (50) | 0.703 |
Well | 5 | 5 (100) | 0 (0) | 2 (40) | 3 (60) | ||
Moderate | 55 | 38 (69) | 17 (31) | 31 (56) | 24 (44) | ||
Poor | 53 | 37 (67) | 16 (33) | 35 (66) | 18 (34) | ||
Stage | |||||||
I | 42 | 32 (76) | 10 (24) | 0.429 | 24 (57) | 18 (43) | 0.657 |
II, III | 75 | 52 (69) | 23 (31) | 46 (61) | 29 (39) | ||
Hepatitis B surface antigen | |||||||
Negative | 59 | 42 (71) | 17 (29) | 0.883 | 39 (66) | 20 (34) | 0.163 |
Positive | 58 | 42 (72) | 16 (28) | 31 (53) | 27 (47) | ||
Hepatitis C virus | |||||||
Negative | 75 | 50 (67) | 25 (33) | 0.201 | 41 (55) | 34 (45) | 0.113 |
Positive | 37 | 29 (78) | 8 (22) | 26 (70) | 11 (30) | ||